Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
Clinical trial NCT05357794 · RECRUITING
Trial details
- NCT number
- NCT05357794
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-13
- Primary completion
- 2027-01-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.